HARNESSING THE REGENERATIVE POWER OF INFLAMMATION
Live / Registered — Registered (as of 03 May 2022)
What this means for you
Registered since 03 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90604160
- Registration number
- 6720358
- Mark type
- Stylized text
- Filed
- 25 Mar 2021
- Published for opposition
- 07 Dec 2021
- Registered
- 03 May 2022
- Attorney of record
- Gwenn Roos
Goods and services
- Class 042 — Scientific and technological services: Medical research; Medical research in the field of infectious diseases; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of inflammation, immunology, regeneration, pain management and reduction, and other neuro- degenerative diseases; Medical and scientific research information in the field of inflammation, immunology, regeneration, pain management and reduction, and other neuro- degenerative diseases; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines; Research and development of vaccines and medicines; Research and development in the field of medicine and pharmaceuticals; Research in the field of inflammation, immunology, regeneration, pain management and reduction, and other neuro- degenerative diseases; Scientific research; Scientific research and development; Scientific research consulting in the field of cosmetics; Scientific research for medical purposes in the field of inflammation, immunology, regeneration, pain management and reduction, and other neuro- degenerative diseases; Scientific consulting and research services relating to foods and dietary supplements; Biochemical research and development; Cell culture services for scientific and research purposes, for others; Genetic testing for scientific research purposes; Pharmaceutical research and development; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research for medical purposes in the area of cancerous diseases
Owner
- CarthroniX, Inc., Tarzana, CA, US
- CarthroniX, Inc., Tarzana, CA, US
- CarthroniX, Inc., Tarzana, CA, US
Prosecution history
- 03 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 29 Mar 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Mar 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Mar 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Feb 2022 — USE AMENDMENT FILED
- 24 Mar 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Feb 2022 — TEAS STATEMENT OF USE RECEIVED
- 01 Feb 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Dec 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Dec 2021 — PUBLISHED FOR OPPOSITION
- 17 Nov 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Nov 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Nov 2021 — EXAMINER'S AMENDMENT ENTERED
- 02 Nov 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Nov 2021 — EXAMINERS AMENDMENT E-MAILED